Global Patient Derived Xenograft/PDX Models Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Patient Derived Xenograft/PDX Models Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Patient Derived Xenograft/PDX Models Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Patient Derived Xenograft/PDX Models Market Performance
• 2.3 USA Patient Derived Xenograft/PDX Models Market Performance
• 2.4 Europe Patient Derived Xenograft/PDX Models Market Performance
• 2.5 Japan Patient Derived Xenograft/PDX Models Market Performance
• 2.6 Korea Patient Derived Xenograft/PDX Models Market Performance
• 2.7 India Patient Derived Xenograft/PDX Models Market Performance
• 2.8 Southeast Asia Patient Derived Xenograft/PDX Models Market Performance
• 2.9 South America Patient Derived Xenograft/PDX Models Market Performance

3 Global Patient Derived Xenograft/PDX Models Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Patient Derived Xenograft/PDX Models Market Performance (Volume)
• 3.3 USA Patient Derived Xenograft/PDX Models Market Performance (Volume)
• 3.4 Europe Patient Derived Xenograft/PDX Models Market Performance (Volume)
• 3.5 Japan Patient Derived Xenograft/PDX Models Market Performance (Volume)
• 3.6 Korea Patient Derived Xenograft/PDX Models Market Performance (Volume)
• 3.7 India Patient Derived Xenograft/PDX Models Market Performance (Volume)
• 3.8 Southeast Asia Patient Derived Xenograft/PDX Models Market Performance (Volume)
• 3.9 South America Patient Derived Xenograft/PDX Models Market Performance (Volume)

4 Competitive Analysis

• 4.1 Crown Bioscience Inc.
  • 4.1.1 Crown Bioscience Inc. Profiles
  • 4.1.2 Crown Bioscience Inc. Product Information
  • 4.1.3 Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.1.4 Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 the Jackson Laboratory
  • 4.2.1 the Jackson Laboratory Profiles
  • 4.2.2 the Jackson Laboratory Product Information
  • 4.2.3 the Jackson Laboratory Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.2.4 the Jackson Laboratory Patient Derived Xenograft/PDX Models Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Champions Oncology, Inc.
  • 4.3.1 Champions Oncology, Inc. Profiles
  • 4.3.2 Champions Oncology, Inc. Product Information
  • 4.3.3 Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.3.4 Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 Charles River Laboratories International, Inc.
  • 4.4.1 Charles River Laboratories International, Inc. Profiles
  • 4.4.2 Charles River Laboratories International, Inc. Product Information
  • 4.4.3 Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.4.4 Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 WuXi Apptec
  • 4.5.1 WuXi Apptec Profiles
  • 4.5.2 WuXi Apptec Product Information
  • 4.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.5.4 WuXi Apptec Patient Derived Xenograft/PDX Models Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 ONCODESIGN
  • 4.6.1 ONCODESIGN Profiles
  • 4.6.2 ONCODESIGN Product Information
  • 4.6.3 ONCODESIGN Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.6.4 ONCODESIGN Patient Derived Xenograft/PDX Models Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Horizon Discovery Group PLC
  • 4.7.1 Horizon Discovery Group PLC Profiles
  • 4.7.2 Horizon Discovery Group PLC Product Information
  • 4.7.3 Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.7.4 Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 Pharmatest Services Ltd.
  • 4.8.1 Pharmatest Services Ltd. Profiles
  • 4.8.2 Pharmatest Services Ltd. Product Information
  • 4.8.3 Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.8.4 Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Hera Biolabs
  • 4.9.1 Hera Biolabs Profiles
  • 4.9.2 Hera Biolabs Product Information
  • 4.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.9.4 Hera Biolabs Patient Derived Xenograft/PDX Models Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 EPO Berlin-Buch GmbH
  • 4.10.1 EPO Berlin-Buch GmbH Profiles
  • 4.10.2 EPO Berlin-Buch GmbH Product Information
  • 4.10.3 EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
  • 4.10.4 EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Xentech
• 4.12 Urolead

5 Competitive Landscape

• 5.1 Global Patient Derived Xenograft/PDX Models Production (K Units) and Market Share by Manufacturers (2014-2019)
• 5.2 Global Patient Derived Xenograft/PDX Models Revenue (M USD) and Market Share by Manufacturers (2014-2019)
• 5.3 Global Patient Derived Xenograft/PDX Models Price (USD/Unit) of Manufacturers (2014-2019)
• 5.4 Global Patient Derived Xenograft/PDX Models Gross Margin of Manufacturers (2014-2019)
• 5.5 Market Concentration

6 Global Patient Derived Xenograft/PDX Models Market Assessment by Regions

• 6.1 Global Patient Derived Xenograft/PDX Models Production (K Units) and Market Share by Regions (2014-2019)
• 6.2 Global Patient Derived Xenograft/PDX Models Revenue (M USD) and Market Share by Regions (2014-2019)
• 6.3 Global Patient Derived Xenograft/PDX Models Price (USD/Unit) by Regions (2014-2019)
• 6.4 Global Patient Derived Xenograft/PDX Models Gross Margin by Regions (2014-2019)

7 Patient Derived Xenograft/PDX Models Regional Analysis

• 7.1 China Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
• 7.2 USA Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
• 7.3 Europe Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
• 7.4 Japan Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
• 7.5 Korea Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
• 7.6 India Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
• 7.7 Southeast Asia Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
• 7.8 South America Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)

8 Global Patient Derived Xenograft/PDX Models Consumption Assessment

• 8.1 Global Patient Derived Xenograft/PDX Models Consumption and Market Share by Regions (2014-2019)
• 8.2 Global Patient Derived Xenograft/PDX Models Consumption Value and Market Share by Regions (2014-2019)
• 8.3 Global Patient Derived Xenograft/PDX Models Average Price (USD/Unit) by Regions (2014-2019)

9 Global Patient Derived Xenograft/PDX Models Sales Assessment by Regions

• 9.1 Global Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.2 China Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.3 USA Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.4 Europe Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.5 Japan Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.6 Korea Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.7 India Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.8 Southeast Asia Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
• 9.9 South America Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2020-2025

• 12.1 Production and Revenue Forecast 2020-2025
  • 12.1.1 Global Patient Derived Xenograft/PDX Models Production and Revenue by Regions 2020-2025
  • 12.1.2 China Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
  • 12.1.3 USA Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
  • 12.1.4 Europe Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
  • 12.1.5 Japan Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
  • 12.1.6 Korea Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
  • 12.1.7 India Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
  • 12.1.8 Southeast Asia Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
  • 12.1.9 South America Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
• 12.2 Sales and Sales Value Forecast 2020-2025
  • 12.2.1 Global Patient Derived Xenograft/PDX Models Consumption and Consumption Calue by Regions 2020-2025
  • 12.2.2 Global Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
  • 12.2.3 China Patient Derived Xenograft/PDX Models Sales, Sales Value and Growth Rate 2020-2025
  • 12.2.4 USA Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
  • 12.2.5 Europe Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
  • 12.2.6 Japan Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
  • 12.2.7 Korea Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
  • 12.2.8 India Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
  • 12.2.9 Southeast Asia Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
  • 12.2.10 South America Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
• 12.3 Global Patient Derived Xenograft/PDX Models Production and Revenue Forecast by Type 2020-2025
  • 12.3.1 Overall Market Performance
  • 12.3.2 Gastrointestinal Tumor Models
  • 12.3.3 Gynecological Tumor Models
  • 12.3.4 Respiratory Tumor Models
  • 12.3.5 Urological Tumor Models
  • 12.3.6 Hematological Tumor Models
  • 12.3.7 Other Tumor Models
• 12.4 Global Patient Derived Xenograft/PDX Models Sales Forecast by Application 2020-2025
  • 12.4.1 Overall Market Performance
  • 12.4.2 Preclinical Drug Development and Basic Cancer Research
  • 12.4.3 Biomarker Analysis
• 12.5 Global Patient Derived Xenograft/PDX Models Price and Gross Margin Forecast
  • 13.5.1 Global Patient Derived Xenograft/PDX Models Averages Price Development Trend Forecast 2020-2025
  • 13.5.2 Global Patient Derived Xenograft/PDX Models Gross Margin Development Trend Forecast 2020-2025

13 Conclusion